Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
基本信息
- 批准号:10580516
- 负责人:
- 金额:$ 15.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease patientAmericanBehaviorBiological ProcessCircadian RhythmsCircadian desynchronyCuesDietDopamine ReceptorDopaminergic CellEventExerciseFoodFood AccessGenetic TranscriptionGoalsHealthHealthcare SystemsHourHumanHypothalamic structureLaboratoriesLightLightingMetabolicMetabolic DiseasesMetabolic dysfunctionMidbrain structureModernizationMolecularNeurodegenerative DisordersNeuronsObesityPalatePathologyPathway interactionsPeriodicityPersonsPhysiologicalPhysiologyPrevalencePublic HealthRewardsSignal TransductionSocial InteractionSocietiesStressTarget PopulationsTimeWeight GainWorkadverse outcomebehavioral responsecircadiancircadian pacemakerdopaminergic neuronfood consumptionhigh riskinsightmouse modelneural circuitneuronal circuitrynovelpressurereduce symptomsresponsesuprachiasmatic nucleustherapeutic target
项目摘要
Project Summary: Biological processes ranging from gene transcription to behavior oscillate and are
synchronized to the 24-hour day/night cycle. Mammalian circadian rhythms, orchestrated by the hypothalamic
suprachiasmatic nucleus (SCN) allow appropriately timed physiological and behavioral responses to daily
recurring external cues (i.e. sunrise or timed meal availability). The resulting synchrony of physiology to the
astronomical day maximizes metabolic efficiency and good health. However, many of the stresses of modern
society (i.e. artificial lighting and omnipresence of food) weaken and desynchronize circadian rhythms. This in
turn increases the prevalence of many pathologies including metabolic disorders and neurodegenerative
diseases. The aim of my laboratory is to determine how circadian rhythms are synchronized to external cues
(circadian entrainment) and how desynchronization impacts health. Although the neuronal pathways of light-
driven entrainment are well-established, how other external cues, such as food availability, social interactions or
exercise, influence the workings of the SCN remains unknown. In a recent breakthrough, we identified a neuronal
connection between midbrain dopaminergic neurons that are activated in response to salient events and SCN
neurons that express the dopamine receptor Drd1. We showed that this pathway accelerates photoentrainment
and drives palatable food consumption outside of mealtimes. In parallel, we identified a novel molecular player
that is necessary for anticipation-related activity to time-restricted food access. Here, we propose to leverage
our expertise in disentangling circadian entrainment neurocircuitry to delineate the mechanisms by which
rewarding cues modulate the SCN circadian clock. Furthermore, we will determine whether strengthening
circadian rhythmicity ameliorates symptoms of neurodegenerative diseases. Our first objective is to gain a
mechanistic understanding of how salient events impact SCN activity and circadian entrainment. We hypothesize
that activation of dopaminergic signaling decreases the amplitude of SCN oscillation and allows faster
photoentrainment. This novel insight will be useful to develop strategies to curb the negative impact of circadian
desynchrony. Our second goal is to identify the midbrain dopaminergic cell population that targets the SCN and
promotes palatable food consumption outside of meal times, leading to weight gain and metabolic disorder. We
predict that by mimicking dopaminergic signaling in the SCN, we will control food consumption. Delineating this
pathway will provide therapeutic targets against diet induced metabolic dysfunction and obesity. Our final
objective is to determine if high amplitude circadian rhythms, by daily consolidation of light and food access, is
sufficient to slow the progression of a mouse model of Alzheimer’s disease (AD). If successful, entrainment
strategies will become potential treatments for AD patients and people with high-risk of developing AD. We
expect our work will provide a better understanding of the relationship between entrainment cues, physiology
and behavior while providing tangible strategies against the adverse consequences of circadian misalignment.
项目概述:从基因转录到行为的生物过程是振荡的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ali Guler其他文献
Ali Guler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ali Guler', 18)}}的其他基金
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
- 批准号:
10437612 - 财政年份:2021
- 资助金额:
$ 15.55万 - 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
- 批准号:
10166690 - 财政年份:2021
- 资助金额:
$ 15.55万 - 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
- 批准号:
10656214 - 财政年份:2021
- 资助金额:
$ 15.55万 - 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
- 批准号:
10793158 - 财政年份:2021
- 资助金额:
$ 15.55万 - 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
- 批准号:
9338266 - 财政年份:2016
- 资助金额:
$ 15.55万 - 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
- 批准号:
10004681 - 财政年份:2016
- 资助金额:
$ 15.55万 - 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
- 批准号:
9193742 - 财政年份:2016
- 资助金额:
$ 15.55万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 15.55万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 15.55万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 15.55万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 15.55万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 15.55万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 15.55万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 15.55万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 15.55万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 15.55万 - 项目类别:














{{item.name}}会员




